Hyperhomocysteinemia is linked to MASLD
Our data suggest an intriguing scenario whereby HHcy is present in patients with MASLD and is associated to lower vitamin D and altered glucose and lipid profile. Thus, considering Hcy levels may help clinicians with the management of patients with increased MASLD risk.
Authors
- Raffaella Maria Gadaleta (ORCID: https://orcid.org/0000-0003-4951-9543)
- Elsa Berardi
- Carlo De Matteis (ORCID: https://orcid.org/0000-0001-6628-2184)
- Antonio Moschetta (ORCID: https://orcid.org/0000-0003-2123-6074)
- Ersilia Di Buduo
- Giusi Graziano (ORCID: https://orcid.org/0000-0002-3347-8049)
- Lucilla Crudele
- Gianfranco Antonica (ORCID: https://orcid.org/0009-0009-0693-6751)
- Silviya Cantatore
- Patrizia Suppressa (ORCID: https://orcid.org/0000-0002-3146-9173)
- Marica Cariello
Institutions
- Istituto Nazionale Biostrutture e Biosistemi (IT)
- Center for Outcomes Research and Clinical Epidemiology (IT)
- University of Bari Aldo Moro (IT)
Publication Details
- Journal
- European Journal of Internal Medicine
- Published
- 2024-10-31
- DOI
- https://doi.org/10.1016/j.ejim.2024.10.014
- Citations
- 19
- Primary Topic
- Folate and B Vitamins Research
- Type
- article
- Field-Weighted Citation Impact
- 8.93